Cargando…

Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model

Renal interstitial fibrosis (IF) is an important pathologic manifestation of disease progression in a variety of chronic kidney diseases (CKD). However, the quantitative and reproducible analysis of IF remains a challenge, especially in experimental animal models of progressive IF. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Hu Sheng, Weldon, Steve M., Matera, Damian, Lee, ChungWein, Yang, Haichun, Fryer, Ryan M., Fogo, Agnes B., Reinhart, Glenn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892485/
https://www.ncbi.nlm.nih.gov/pubmed/27257917
http://dx.doi.org/10.1371/journal.pone.0156734
_version_ 1782435396334911488
author Qian, Hu Sheng
Weldon, Steve M.
Matera, Damian
Lee, ChungWein
Yang, Haichun
Fryer, Ryan M.
Fogo, Agnes B.
Reinhart, Glenn A.
author_facet Qian, Hu Sheng
Weldon, Steve M.
Matera, Damian
Lee, ChungWein
Yang, Haichun
Fryer, Ryan M.
Fogo, Agnes B.
Reinhart, Glenn A.
author_sort Qian, Hu Sheng
collection PubMed
description Renal interstitial fibrosis (IF) is an important pathologic manifestation of disease progression in a variety of chronic kidney diseases (CKD). However, the quantitative and reproducible analysis of IF remains a challenge, especially in experimental animal models of progressive IF. In this study, we compare traditional polarized Sirius Red morphometry (SRM) to novel Second Harmonic Generation (SHG)-based morphometry of unstained tissues for quantitative analysis of IF in the rat 5 day unilateral ureteral obstruction (UUO) model. To validate the specificity of SHG for detecting fibrillar collagen components in IF, co-localization studies for collagens type I, III, and IV were performed using IHC. In addition, we examined the correlation, dynamic range, sensitivity, and ability of polarized SRM and SHG-based morphometry to detect an anti-fibrotic effect of three different treatment regimens. Comparisons were made across three separate studies in which animals were treated with three mechanistically distinct pharmacologic agents: enalapril (ENA, 15, 30, 60 mg/kg), mycophenolate mofetil (MMF, 2, 20 mg/kg) or the connective tissue growth factor (CTGF) neutralizing antibody, EX75606 (1, 3, 10 mg/kg). Our results demonstrate a strong co-localization of the SHG signal with fibrillar collagens I and III but not non-fibrillar collagen IV. Quantitative IF, calculated as percent cortical area of fibrosis, demonstrated similar response profile for both polarized SRM and SHG-based morphometry. The two methodologies exhibited a strong correlation across all three pharmacology studies (r(2) = 0.89–0.96). However, compared with polarized SRM, SHG-based morphometry delivered a greater dynamic range and absolute magnitude of reduction of IF after treatment. In summary, we demonstrate that SHG-based morphometry in unstained kidney tissues is comparable to polarized SRM for quantitation of fibrillar collagens, but with an enhanced sensitivity to detect treatment-induced reductions in IF. Thus, performing SHG-based morphometry on unstained kidney tissue is a reliable alternative to traditional polarized SRM for quantitative analysis of IF.
format Online
Article
Text
id pubmed-4892485
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48924852016-06-16 Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model Qian, Hu Sheng Weldon, Steve M. Matera, Damian Lee, ChungWein Yang, Haichun Fryer, Ryan M. Fogo, Agnes B. Reinhart, Glenn A. PLoS One Research Article Renal interstitial fibrosis (IF) is an important pathologic manifestation of disease progression in a variety of chronic kidney diseases (CKD). However, the quantitative and reproducible analysis of IF remains a challenge, especially in experimental animal models of progressive IF. In this study, we compare traditional polarized Sirius Red morphometry (SRM) to novel Second Harmonic Generation (SHG)-based morphometry of unstained tissues for quantitative analysis of IF in the rat 5 day unilateral ureteral obstruction (UUO) model. To validate the specificity of SHG for detecting fibrillar collagen components in IF, co-localization studies for collagens type I, III, and IV were performed using IHC. In addition, we examined the correlation, dynamic range, sensitivity, and ability of polarized SRM and SHG-based morphometry to detect an anti-fibrotic effect of three different treatment regimens. Comparisons were made across three separate studies in which animals were treated with three mechanistically distinct pharmacologic agents: enalapril (ENA, 15, 30, 60 mg/kg), mycophenolate mofetil (MMF, 2, 20 mg/kg) or the connective tissue growth factor (CTGF) neutralizing antibody, EX75606 (1, 3, 10 mg/kg). Our results demonstrate a strong co-localization of the SHG signal with fibrillar collagens I and III but not non-fibrillar collagen IV. Quantitative IF, calculated as percent cortical area of fibrosis, demonstrated similar response profile for both polarized SRM and SHG-based morphometry. The two methodologies exhibited a strong correlation across all three pharmacology studies (r(2) = 0.89–0.96). However, compared with polarized SRM, SHG-based morphometry delivered a greater dynamic range and absolute magnitude of reduction of IF after treatment. In summary, we demonstrate that SHG-based morphometry in unstained kidney tissues is comparable to polarized SRM for quantitation of fibrillar collagens, but with an enhanced sensitivity to detect treatment-induced reductions in IF. Thus, performing SHG-based morphometry on unstained kidney tissue is a reliable alternative to traditional polarized SRM for quantitative analysis of IF. Public Library of Science 2016-06-03 /pmc/articles/PMC4892485/ /pubmed/27257917 http://dx.doi.org/10.1371/journal.pone.0156734 Text en © 2016 Qian et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Qian, Hu Sheng
Weldon, Steve M.
Matera, Damian
Lee, ChungWein
Yang, Haichun
Fryer, Ryan M.
Fogo, Agnes B.
Reinhart, Glenn A.
Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model
title Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model
title_full Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model
title_fullStr Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model
title_full_unstemmed Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model
title_short Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model
title_sort quantification and comparison of anti-fibrotic therapies by polarized srm and shg-based morphometry in rat uuo model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892485/
https://www.ncbi.nlm.nih.gov/pubmed/27257917
http://dx.doi.org/10.1371/journal.pone.0156734
work_keys_str_mv AT qianhusheng quantificationandcomparisonofantifibrotictherapiesbypolarizedsrmandshgbasedmorphometryinratuuomodel
AT weldonstevem quantificationandcomparisonofantifibrotictherapiesbypolarizedsrmandshgbasedmorphometryinratuuomodel
AT materadamian quantificationandcomparisonofantifibrotictherapiesbypolarizedsrmandshgbasedmorphometryinratuuomodel
AT leechungwein quantificationandcomparisonofantifibrotictherapiesbypolarizedsrmandshgbasedmorphometryinratuuomodel
AT yanghaichun quantificationandcomparisonofantifibrotictherapiesbypolarizedsrmandshgbasedmorphometryinratuuomodel
AT fryerryanm quantificationandcomparisonofantifibrotictherapiesbypolarizedsrmandshgbasedmorphometryinratuuomodel
AT fogoagnesb quantificationandcomparisonofantifibrotictherapiesbypolarizedsrmandshgbasedmorphometryinratuuomodel
AT reinhartglenna quantificationandcomparisonofantifibrotictherapiesbypolarizedsrmandshgbasedmorphometryinratuuomodel